News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Videos|February 4, 2022

DSM-V Diagnostic Criteria for Sleep Disorders

Experts in sleep disorders review the DSM-V Diagnostic Criteria for insomnia disorder and discuss sleep disorder permutations.

Episodes in this series

EP. 1 Overview and Incidence of Insomnia Disorder

EP. 1 Overview and Incidence of Insomnia Disorder

EP. 2 DSM-V Diagnostic Criteria for Sleep Disorders

EP. 2 DSM-V Diagnostic Criteria for Sleep Disorders

EP. 3 Overview of Parasomnias

EP. 3 Overview of Parasomnias

EP. 4 Treatments for Parasomnia and Sleep Disorders

EP. 4 Treatments for Parasomnia and Sleep Disorders

EP. 5 Disorders and COVID-19

EP. 5 Disorders and COVID-19

EP. 6 Insomnia: Treatment and Management Considerations

EP. 6 Insomnia: Treatment and Management Considerations

EP. 7 Insomnia Clinical Practice Pearls

EP. 7 Insomnia Clinical Practice Pearls

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

full house

Monoamines: A Full House

ByJohn J. Miller, MD

June 10th 2026

Wiman/Adobe Stock

Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD

ByKim Do, PhD,Jessica Walters

June 3rd 2026

Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy

ByWilliam Li, MD,Morgan Hardy, MD

June 2nd 2026

Psycho-Oncology: The Relationship of Cancer and Psychiatric Care

Psycho-Oncology: The Relationship of Cancer and Psychiatric Care

ByMichelle B. Riba, MD, MS

May 18th 2026

Computational Phenotyping of Schizophrenia: Measuring Language and Facial Expression

Computational Phenotyping of Schizophrenia: Measuring Language and Facial Expression

ByCheryl Corcoran, MD

May 17th 2026

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Monoamines: A Full House

Understanding the Complexities of Suicide Risk: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD

Next Generation Pharmacotherapies for Mood and Anxiety Disorders: An ASCP Poster Presentation Recap